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Exercise-based self-management interventions are recommended for lung cancer survivors 52 
and can provide physical, psychosocial and emotional relief. Mobile health technologies can 53 
encourage self-management; however, currently no cancer-related apps address exercise 54 
specific needs of lung cancer survivors. This paper details the design, development and 55 
testing of an exercise app for lung cancer survivors (iEXHALE) which aims to increase 56 
exercise activity and improve symptoms.   57 
Methods 58 
The research had two stages: 1) focus groups with healthcare professionals, patients and 59 
family members (n=21) 2) app development and usability study with lung cancer survivors 60 
(n=6). The Capability, Opportunity, Motivation-Behaviour model was used as a theoretical 61 
framework; data were thematically analysed. 62 
Results 63 
Focus group findings identified many helpful exercises for managing lung cancer survivors’ 64 
symptoms. These findings, alongside relevant literature, informed iEXHALE’s content and 65 
design. The usability study found that lung cancer survivors valued iEXHALE’s self-66 
management capabilities, but identified potential modifications, including improved self-67 
monitoring diaries and navigation.   68 
Conclusions 69 
iEXHALE’s development has been theoretically and empirically informed, showing value as a 70 
self-management tool. Next, we will test its effectiveness, acceptability and cost-71 
effectiveness.  72 
Keywords: Cancer, Depression, Exercise, Fatigue, Lung Cancer, Mobile Health, Oncology,  73 
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Lung cancer is the most prevalent cancer globally, contributing to around 13% of cancer 78 
cases [1]. Europe and North America have the highest incidence [1], with 36,761 new cases 79 
in England in 2016 [2]. Over a third of lung cancer patients in England and Wales survive for 80 
one year or more and 10% survive five years or more [2-3].  81 
Despite advances in survival rates many lung cancer survivors (LCS) have unmet mental, 82 
physical and psychosocial needs following treatment [4], which includes surgery, 83 
immunotherapy, chemotherapy and radiotherapy [5]. Treatment can exacerbate 84 
breathlessness, fatigue and depression due to enforced lifestyle changes and the struggle to 85 
accept a ‘new normality’ [5-7]. Lung cancer’s ‘stigma’ [8] and feelings of isolation following 86 
treatment can result in reduced activities of daily living, increased social isolation, decreased 87 
health and fitness and ability to return to work [9-10]. Most LCS feel they lack support from 88 
health or social care services once treatment finishes [4]. 89 
A systematic review examining the effectiveness of exercise interventions in improving 90 
breathlessness, fatigue and depression in LCS [11] highlighted the need for tailored self-91 
management support to optimise treatment outcomes and symptom control. Key findings 92 
suggested many exercise interventions are beneficial and generally acceptable to LCS, can 93 
be adopted daily and that different treatment pathways can impact on their effectiveness 94 
[11]. Exercise can relieve physical, psychosocial and emotional burdens from cancer [4], 95 
increasing empowerment, self-efficacy, quality of life, coping mechanisms, health 96 
behaviours and outcomes and decreasing fatigue and depression [12-17]. However, less 97 
than one third of LCS meet recommended exercise guidelines to reduce time spent 98 
sedentary, increase strength and balance building activities and undertake 150 minutes 99 
aerobic activity per week [18, 19].  100 
Mobile health technologies can encourage patients to self-manage their health behaviours 101 
and are feasible, acceptable and effective approaches to providing supportive care [20-24]. 102 
However, mobile health interventions to enhance exercise for cancer survivors remain 103 
uncommon [25] and of the cancer-related apps available [26, 27], none are aimed at, or 104 
address, the specific exercise needs of lung cancer survivors [28]. 105 




This paper reports on a programme of research consisting of focus groups, app 106 
development and a usability study which aimed to design, develop and test an exercise app 107 
for LCS (iEXHALE) to help increase exercise activity and improve symptoms of 108 
breathlessness, fatigue and depression.   109 
We provide an overview of the steps undertaken to create a tailored, evidence-based e-110 
health resource for LCS, divided into two studies: 1) qualitative focus groups 2) prototype 111 
app development and usability study (Figure 1). STROBE reporting guidelines [29] enhanced 112 
transparency of the research process. 113 
Study 1: Focus groups 114 
Methods 115 
Focus groups explored how exercise can improve breathlessness, fatigue and depression in 116 
LCS. Key objectives were to identify: 117 
• exercise interventions that improve symptoms 118 
• facilitators and barriers to exercise   119 
• behavioural change techniques to inform iEXHALE’s development 120 
Separate focus groups were organised for primary and secondary care professionals, LCS 121 
and their families. A combined focus group was conducted for LCS and family members, due 122 
to the different perspectives gathered through shared experiences of illness. In addition, 123 
some LCS relied on family to accompany them.  Separate primary and secondary care focus 124 
groups were held due to differing time commitments. 125 
The focus groups took place at an NHS Foundation Trust and a primary care centre in South 126 
West England. The trust is a tertiary centre and large teaching hospital, with an established 127 
cancer centre, whilst the primary care centre comprised a large multi-disciplinary team. 128 
NHS HRA Ethics approvals were obtained (17/LO/1576; IRAS ID 231738).  129 
Convenience sampling was used; lung cancer nurse specialists screened clinic lists to identify 130 
eligible LCS treated at the cancer centre. Eligible participants were over 18 years old, had 131 




completed curative intent treatment within six months of study entry, had stable disease 132 
and were able to provide written informed consent. Eligible patients were provided with 133 
participant information leaflets (PILs) and, if interested, were put in touch with the 134 
researchers (CH/ZD).  135 
Primary and secondary care staff were accessed by contacting a local general practitioner 136 
and lung cancer nurse specialist, respectively, who distributed PILs to colleagues. 137 
Participants were selected using convenience sampling: any healthcare professionals who 138 
worked with cancer patients were invited to participate.  139 
Focus groups for patients/families were held at a Maggie’s centre on the hospital premises; 140 
participants were offered travel reimbursements. The secondary care focus group was held 141 
in a hospital meeting room and the primary care focus group at the primary care centre. 142 
Refreshments were provided. Prior to commencing, participants provided written informed 143 
consent. Focus group discussions were moderated and facilitated by the researchers 144 
(CH/ZD) and were guided by a semi-structured topic guide (supplementary file). This was 145 
informed by systematic review findings examining the effectiveness of exercise 146 
interventions in improving symptom control in LCS [11]. Focus groups lasted one hour, were 147 
digitally recorded and were transcribed by a local transcription company.  148 
Data analysis was two-fold. During stage one, data were analysed thematically using the 149 
Framework Method [30]. Focus group transcripts were coded (ZD); two were double-coded 150 
(ZD, CH). Emerging themes were critiqued during study meetings to ensure transparency 151 
and consistency in data analysis and interpretation.  152 
During stage two, data were mapped against and theoretically underpinned by the COM-B 153 
Framework for Behaviour Change and the Theoretical Domains Framework [31], using a 154 
deductive framework for analysis.  This is an integrative theoretical framework for 155 
understanding target behaviours and designing interventions, including e-health and m-health 156 
interventions, instead of looking to single theoretical models. The framework splits influences on 157 
behaviour change into three components: ‘C’apability, ‘O’pportunity and ‘M’otivation. 158 
These components are matched with ‘intervention functions’ such as ‘incentivisation’ and 159 
‘training’, which link to appropriate behaviour change techniques such as ‘rewards’ and 160 




‘goal-setting’. This approach has been used by healthcare researchers to develop and 161 
implement tailored interventions [32, 33].  162 
Findings 163 
Participant characteristics 164 
Twenty-one participants were recruited (Table 1). Four focus groups were undertaken, one 165 
with secondary care professionals (n=5), one with primary care professionals (n=6) and two 166 
with patients/family members (n=8). The size of the focus groups is in line with the 167 
literature on focus group methodology and allowed data saturation to be achieved [34]. 168 
Face-to-face interviews (n=2) were undertaken with patients who could not attend focus 169 
groups. All patient participants had a performance status of 0-1. 170 
Main findings 171 
Participants identified many exercises that they felt helped LCS to manage symptoms, 172 
including activities of daily living, yoga, tai chi, walking, cycling, exercise classes, running, 173 
resistance and strength training, golf, pilates, light stretching, breathing techniques, 174 
mindfulness and swimming. Supervised and unsupervised, group and individual, and low 175 
(e.g. walking) and high (e.g. running) intensity exercise activities were considered useful.  176 
Themes relating to COM-B emerged from the dataset which were relevant for developing 177 
iEXHALE: 178 
Capability 179 
Physical skills  180 
All patient participants reported being affected by at least one debilitating symptom of 181 
breathlessness, fatigue or depression. All participants recognised that differences in 182 
performance status and symptom experience could affect which exercises LCS might want, 183 
or be able to, participate in.  184 
 “It’s a very broad group of patients that we’re talking about, from someone that’s a 185 
performance status zero to four, so it’s very dependent on the person” (Healthcare 186 
professional FG2) 187 





Most participants felt that LCS usually knew of the importance of exercise in recovery; 189 
however, they emphasised the relevance of timely, structured, tailored and professional 190 
advice for managing symptoms and accessing exercise interventions. Patients valued 191 
information from healthcare professionals and noted that knowledge provision via an app 192 
could be a convenient information provider. 193 
“If you can go on[line] and find out your bits and pieces and whatever you need to, 194 
then it’s got to be a good thing…We are living in an age now, aren’t we, that 195 
everything is done online really.” (Patient/family FG3) 196 
Behavioural regulation (self-monitoring, action-planning, habit formation, breaking habit) 197 
Health professionals stated that exercise guidance that facilitated patients’ decision-making 198 
might be helpful, whilst patients noted benefits of following exercise programmes. 199 
 “She'd give me a program every week...She used to put me on the bike and then I 200 
did some weights...Then she put me on the treadmill…Actually I didn't want to come 201 
off it." (Patient/family FG1) 202 
All participants felt that patients who engaged in exercise prior to diagnosis would find it 203 
easier to exercise post-treatment than those needing to initiate new exercise habits.  204 
"Someone down the road may not attend because it’s their history of poor 205 
exercising" (Healthcare professional FG2) 206 
Opportunity     207 
Environmental context/resources 208 
Healthcare professionals felt that location and access to transport were key to exercise 209 
engagement. Similarly, patients/family members commented that, although willing to travel 210 
to exercise, distance, time, transport links, assistance with transportation and parking 211 
influenced this decision. Cost was not considered a factor. However, patients reported 212 
varying preferences around exercising at home, in group, or individual settings and many 213 
were frustrated at the lack of hospital-based exercise provision.  214 




 “[The hospital exercise class] ended…I wanted to [continue], but I couldn’t.” 215 
(Patient/family FG1) 216 
Social influences 217 
All participants commented that patients’ levels of social engagement, with family, carers, 218 
colleagues or pets, could influence exercise uptake. Patients identified the role of healthcare 219 
professionals and other role models (e.g., personal trainers) in continued exercise 220 
engagement, by setting and redefining targets, reducing anxiety and providing an element 221 
of accountability.  222 
 “Having the accountability helps. It’s the same if you compare it to a Weight 223 
Watcher’s group…The people that attend the groups every week tend to do the 224 
best.” (Healthcare professional FG2) 225 
Motivation 226 
Professional/social and role identity 227 
Gender, age, role obligations, lung cancer’s stigma and disrupted feelings of normality were 228 
considered potential barriers to exercise engagement, often impacting on mood and 229 
motivation.  230 
“The people that engage at the higher levels of intervention have been female and 231 
within an age thing…People do think, well, I’ve had a good innings anyway.” 232 
(Healthcare professional FG2) 233 
Beliefs about capabilities and optimism  234 
Patients reported various beliefs about their capability and optimism for exercise which 235 
fluctuated throughout recovery according to changes in fitness, health status or prognosis.  236 
“I don't go too far. I'll stop and take a couple of deep breaths and then move on. Or 237 
I'll slow up." (Patient/family FG1) 238 
Beliefs about consequences 239 




Patients/family members displayed positive beliefs about and experiences of the impact of 240 
exercise on symptom control, as well as wider benefits to overall health and wellbeing, and 241 
were generally willing to explore new exercises. 242 
“If there is anything there that can assist you, then why not use it…If it makes you 243 
feel better” (Patient/family FG3) 244 
 However, caution and fear of causing damage was apparent. 245 
 “Because of the surgical emphysema I had… Of course, I don't want that to come 246 
back. And I'm conscious of that when I'm thinking about exercise. " (Patient/family 247 
FG1) 248 
Intentions and Goals 249 
Most participants commented that exercise intent was influenced by changing health status, 250 
symptom experience and progress in survivorship. They felt exercise goals should focus on 251 
improving fitness, symptom management, avoiding illness, or improving quality of life and 252 
these goals should be realistic, self-set, specific and clear. 253 
“Feeling better…whether that’s physically or psychologically…For some patients it 254 
might be that they’re leaving the house and meeting people, and for others it might 255 
be that they’re doing something that’s hopefully going to improve their symptoms.” 256 
(Healthcare professional FG2) 257 
Reinforcement 258 
Remote monitoring and feedback were recognised as potential incentives to exercise by 259 
healthcare professionals. 260 
 “A lot of people have smart phones…[Or] come with in-built health pedometers...I 261 
think there definitely is the utilisation of that piece of equipment.” (Healthcare 262 
professional FG2) 263 
Emotions 264 
All participants perceived negative emotional reactions to symptom experience and 265 
exercise, including fear and pain, as exercise deterrents.  266 




“They would think this is horrible because it reminds of what lung cancer is like, and 267 
this is why I’m short of breath. It makes me anxious and I’m going to die. So they 268 
don’t want to do it. It’s that sort of cognitive cycle rather than I’m going to be push 269 
and be strong.” (Healthcare professional FG1) 270 
 271 
Study 2: Prototype development and usability study 272 
Methods 273 
Findings of study 1 and the systematic review [11], enabled iEXHALE prototype 1 to be 274 
developed with an app development company (Phase 0), adopting a user-centred approach 275 
focusing on user-flow through the app. Design features and content were theoretically 276 
grounded (using COM-B) and targeted at the needs and preferences of LCS. Prototype 1 277 
included four core sections: an introduction containing information about lung cancer; a 278 
section for generating recommended exercises by rating symptoms and inputting 279 
preferences; a section containing information about recommended exercises; a self-280 
monitoring diary for recording activity (Table 2). The evidence-based algorithm 281 
underpinning the self-rating symptom section was designed specifically for the app, and 282 
used information inputted by users to generate three exercises that are known to benefit 283 
the symptoms experienced, as well as responding to user preferences for exercise location, 284 
intensity, and individual/group type.   Google analytics software was embedded within the 285 
app to examine participants’ interactions with the different sections. 286 
A usability study was designed to test the app’s effectiveness, efficiency and simplicity. The 287 
usability study protocol has been detailed elsewhere [35]. The study consisted of three 288 
consecutive phases, each interspersed with elements of data analysis and app prototype 289 
redevelopment.  NHS HRA Research Ethics Committee approvals were obtained (IRAS 290 
number: 239116).  291 
Patients/family members from Study 1 were invited to participate, provided they had access 292 
to a smartphone or electronic device. Eligible participants were posted or emailed a PIL and 293 
were contacted one week later by a researcher to confirm their participation. 294 




The study took place at Oxford Brookes University; all participants provided written 295 
informed consent. During phase 1 (figure 1), participants completed a pre-test Mobile 296 
Device Proficiency (MDPQ-16) survey [36] to assess smartphone usage. Participants then 297 
completed tasks in a university setting using prototype 1, which were quantitatively and 298 
qualitatively evaluated. Metrics, including task completion, completion attempts, 299 
completion time, clicks/touches to complete, error rate, type and severity, were used to 300 
assess technical usability of the app. The ‘think aloud’ technique was used to assess the 301 
user’s experience of the app.  ‘Think aloud’ behaviours and video recordings of participants 302 
hands on the device were recorded for analysis. Participants also completed a post-test 303 
Systems Usability Scale (SUS) [37], a reliable questionnaire using a 5-point likert scale 304 
(strongly agree-strongly disagree) that measures user perceptions of web-based 305 
applications ease of use. Findings informed the app’s redevelopment (prototype 2), before 306 
phase 2 commenced, replicating phase 1’s activities. During phase 3, participants used 307 
prototype 2 for two weeks before attending individual, semi-structured interviews to 308 
describe their user-experiences. 309 
Qualitative data from the ‘think aloud’ tasks and interviews were analysed thematically 310 
using the Framework Method [30]. Descriptive statistics were produced for quantitative 311 
metrics and examined against literature on thresholds for acceptability (usability), 312 
effectiveness (completion and error rates) and efficiency (task-times) [38].  313 
Findings 314 
Participant characteristics 315 
Six participants were recruited, enough for maximising the expected level of problem 316 
discovery within technical application development [39]. Table 3 presents participant 317 
demographics, pre- and post-task survey data. One participant (UX3) was a family member.  318 
Main findings  319 
One participant (UX1) was excluded from the analysis due to incomplete data. MDPQ-16 320 
scores indicated low to moderate mobile device proficiency.  SUS scores increased or 321 
remained consistent between phases 1 and 2 in four participants, with most phase 2 scores 322 
achieving okay (50 > SUS > 70) or good (SUS > 70) levels of acceptability. Phase 1&2 tasks 323 




highlighted issues with participants’ accuracy, completion of logins and self-monitoring 324 
diaries. However, the overall task completion rate was high for tasks completed in under 10 325 
minutes, with changes observed between phase 1 (83%) and phase 2 (87%). Most 326 
participants completed tasks after one attempt (85%). Overall relative efficiency changed 327 
from 95% in phase 1 to 96% in phase 2. The app appeared simple to use, with errors per 328 
task ranging from 0.4 – 2.6; these consisted predominantly of participants selecting the 329 
wrong icon, making incorrect gestures, or making navigation errors (70%). User frustration 330 
per task was rated by researchers as ‘zero to little frustration’ for 67% of participants in 331 
phase 1 and 77% in phase 2, with the remainder rated as ‘medium/high frustration’ or ‘point 332 
of failure’. ‘Think aloud’ commentary from participants was minimal and primarily consisted 333 
of comments about app navigation. 334 
During phase 3, participants identified app strengths and weaknesses across four themes: 335 
Access, format, and presentation; self-rating symptoms and exercise recommendations; 336 
self-monitoring diaries; future use. 337 
Access, format and presentation 338 
Participants liked the app’s aesthetics and incorporating it into daily life. Most participants 339 
used the app regularly and those who accessed the app least were not accessing it via a 340 
mobile device.  341 
“It’s nice and friendly…I like the logo on it” (UX1) 342 
Individual preferences for content presentation emerged. However, participants were 343 
positive about text and audio-visual content that established links with healthcare 344 
professionals. 345 
 “It gives you that sense of safety because of course they know what they’re talking 346 
about.” (UX5) 347 
The app pathway was not always clear to participants who felt that better sign-posting 348 
would have improved navigation and facilitated better use of app sections.  349 
“I’m having to sort of go into the menu… and you’re scrolling away and reading, and 350 
you go, hang on, I’ve done this” (UX4) 351 




Self-rating symptoms and exercise generation 352 
Participants liked customising their exercise preferences and ranking their symptom severity 353 
to produce bespoke exercise recommendations, finding this useful and motivating.  354 
“You can put in pretty much every day how you’re feeling… I think it’s brilliant. I 355 
think it does give you a little push to actually think perhaps I ought to go for a walk” 356 
(UX5) 357 
Self-monitoring diaries 358 
Whilst the diaries worked well for some, most participants felt they lacked complexity, 359 
interactivity, and flexibility and were not being utilised fully. 360 
“It’s not reacting to information that I’m putting in, it’s not an interactive app.” (UX4) 361 
Future use 362 
Participants believed the app could help LCS during follow-up and those with other cancers 363 
or chronic respiratory conditions and highlighted its benefit as a motivating self-364 
management tool. Some participants said they would use the app frequently, although they 365 
believed the length of time this would continue was limited.  366 
“If I was a physician or surgeon…This would be definitely something I would say well, 367 
there are one or two things we can do. The NHS can’t cope…But here is something 368 
you could do for yourself, which would be incredibly valuable if it suits you.” (UX6) 369 
Conclusions 370 
We have developed an empirically and theoretically informed exercise app to help LCS 371 
increase their exercise activity and improve symptom control. Using COM-B [30], relevant 372 
capabilities, opportunities and motivations associated with exercise engagement were 373 
identified [30], which enabled relevant app features to be identified during iEXHALE’s 374 
development. iEXHALE’s development is timely, as whilst numerous apps have aimed to 375 
enhance physical activity in people with chronic illnesses such as diabetes and heart failure 376 
[25], few apps are available to cancer survivors. Where these apps do exist [26, 27] they fail 377 




to focus specifically on the exercise needs of lung cancer survivors, something iEXHALE has 378 
achieved. 379 
The usability study enabled iEXHALE’s features to be assessed by LCS, allowing the 380 
researchers to identify which features are favoured and which need improvement. 381 
Specifically, the self-monitoring diaries, although identified as useful, were deemed 382 
ineffective in their current form, highlighting a need for prototype redevelopment.  383 
Participants’ shared consensus of iEXHALE as a useful self-management tool for LCS, 384 
providing flexible, customised exercise information that can be utilised and adapted to meet 385 
individual needs and preferences, is encouraging, and demonstrates its value to this 386 
population group. However, all patient participants had a performance status of 0-1 and 387 
were relatively active. Further research into iEXHALE’s usefulness for patients with 388 
performance statuses of ≥2, would confirm its generalisability to the wider LCS population. 389 
iEXHALE has been developed for use in the NHS and aligns with recent National Institute for 390 
Health and Care Excellence (NICE) evidence standards for digital health technologies (40), 391 
which emphasise a dynamic, value driven approach to their development and 392 
commissioning to ensure relevance to patients (40). NICE also state that rehabilitation from 393 
cancer should promote patients’ ability to function, independence and adaptation to their 394 
condition (41) and that this can be enabled through active self-management (41), something 395 
that is central to iEXHALE. 396 
Study Limitations  397 
The lack of ethnic diversity and the older age of participants provide study limitations, as the 398 
population sampled was not representative of the general population; however, it was 399 
representative of a large demographic of LCS. Social desirability bias during the usability 400 
study interviews was possible, if participants perceived a favourable response about the app 401 
to be more acceptable. However, the quantitative usability findings suggested regular use of 402 
the app in general, indicating that it was helpful to participants. Finally, no secondary care 403 
consultants or primary care nurses participated in the focus groups; their perspectives may 404 
have added insights to the findings. 405 
 406 




Clinical implications 407 
Findings have widespread implications on an international level, by demonstrating the 408 
potential for an interactive, tailored digital resource to provide symptom management 409 
support to LCS. We have detailed a methodology for developing technologies targeted at 410 
older people with chronic conditions. Our approach can be applied to other disease groups 411 
and older people who are not traditionally engaged with e-health interventions; this is 412 
especially pertinent at a time when the ageing population is increasing globally.  413 
iEXHALE has been designed with patients, for patients, has utilised the wider literature [11] 414 
and the views of those central to LCS’ follow-up pathways. The app can benefit both LCS 415 
entering follow-up and healthcare professionals looking to provide a supportive, self-416 
management resource to patients. We intend to make modifications to iEXHALE based on 417 
the usability findings, before testing its effectiveness, acceptability and cost-effectiveness in 418 
a multi-centre study, to enhance generalisability. This will determine whether the app 419 
should be made widely available to LCS entering follow-up. Future work will explore the 420 
potential for iEXHALE to be adapted for patients with other cancer types and respiratory 421 
diseases. 422 
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Table 1: Focus group participant demographics 571 
















Age (years) 18-39 0 0 1 2 3 
40-59 0 0 2 2 4 
60-79 5 2 - - 7 
80+ 2 1 0 0 3 
Ethnicity White 7 3 5 5 20 
Asian 0 0 1 0 1 
Sex Male 3 2 3 1 9 
Female 4 1 3 4 12 
Cancer type Non-small cell 2     










Clinical role General 
practitioner 
  5 0 5 
Practice Manager 1 0 1 
Lung cancer nurse 
specialist 
0 4 4 




1-5   1 - 0 
6-10 1 2 3 
11-15 - - 0 















Table 2: Core sections of iEXHALE (prototype 1) 582 
Section  Content Screenshot 
Introduction  Information about lung cancer and its treatment, 
common symptoms of fatigue, breathlessness and 
depression, and benefits of exercise for improving 
symptoms.  
         
Self-rating 
symptoms 
Users rate symptom severity, preferred activity level, 
and preferences for group/individual exercise 
activities. This information is used to generate three 
recommended exercises. 
         
Exercise 
information 
Users are provided with further information about 
three recommended exercises. Including information 
about how to access these exercise and, where 
necessary, video demonstrations on how to 
complete these.  
           
Self-monitoring 
diaries 
Participants rate their current symptoms and 
indicate how often they have undertaken 
recommended exercise activities each week (type, 
duration, subjective rating). Email reminders sent to 
participants.  












Table 3: Participant demographics and usability metrics 590 
Demographics UX1 UX2 UX3 UX4 UX5 UX6 
Age 61-70 >70 >70 >70 51-60 >70 
Gender Female  Female Female Male Female Male 
Skill level Intermediate Intermediate Intermediate Novice Novice Novice 
Use frequency Daily Hardly ever Daily Daily Daily Hardly ever 
Home Device N.K. Computer Apple iPhone Apple iPhone Sony Xperia Computer 
MDPQ N.K. 15.5 21.5 39 23.5 11.5 
SUS Phase 1 87.5 37.5 57.5 80 100 57.5 
SUS Phase 2 NK 57.5 75 80 100 45 
 591 
 592 
Figure Legends 593 
 594 
Figure 1: Study flow diagram depicting the sequential phases of development of the iEXHALE app  595 
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 597 
